RASICA
"RASICA" is a word mark owned by Hangzhou Adlai Nortye Biopharma Co., Ltd., filed at the USPTO on June 2, 2026. It is waiting to be published and covers class 42 (Computer and Scientific Services).
- Status
- Awaiting publication
- Since October 15, 2026
- Filed
- June 2, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99860254
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns RASICA
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Hangzhou Adlai Nortye Biopharma Co., Ltd.
Hangzhou, China
Representative
Michael K. Kinney
Dilworth IP, LLC
What the mark covers
The products and services RASICA is filed for, grouped by Nice class.
Scientific research for medical purposes in the area of cancerous diseases; Medical research services in the field of cancer; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Medical research laboratories; Development of pharmaceutical preparations and medicines; Testing of pharmaceuticals; Pharmaceutical product evaluation
What has happened so far
Steps recorded by the USPTO, newest first.
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Assigned to examiner
- New application office supplied data entered
- Application filing receipt mailed
- New application entered
About RASICA
Who owns the trademark "RASICA"?
The USPTO trademark "RASICA" (application 99860254) is owned by Hangzhou Adlai Nortye Biopharma Co., Ltd.
What is the status of "RASICA"?
Its status at the USPTO is: awaiting publication.
Get this data via the API
Everything on this page comes from the Signa API. Pull RASICA and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019e9110-b19b-754f-be3f-e6be0a619c3f
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019e9110-b19b-754f-be3f-e6be0a619c3f",
"object": "trademark",
"mark_text": "RASICA",
"status": {
"primary": "pending",
"stage": "pending_publication"
},
"office_code": "US",
"application_number": "99860254",
"filing_date": "2026-06-02",
"nice_classes": [
42
],
"owners": [
{
"name": "Hangzhou Adlai Nortye Biopharma Co., Ltd.",
"entity_id": "ent_019ebafe-592e-74fc-94b9-7df55a5ed453"
}
]
}